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Abstract
Fast and accurate synaptic transmission requires high-density accumulation of neurotransmitter
receptors in the postsynaptic membrane. During development of the neuromuscular junction, clustering
of acetylcholine receptors (AChR) is one of the first signs of postsynaptic specialization and is induced
by nerve-released agrin. Recent studies have revealed that different mechanisms regulate assembly vs
stabilization of AChR clusters and of the postsynaptic apparatus. MuSK, a receptor tyrosine kinase and
component of the agrin receptor, and rapsyn, an AChR-associated anchoring protein, play crucial roles
in the postsynaptic assembly. Once formed, AChR clusters and the postsynaptic membrane are
stabilized by components of the dystrophin/utrophin glycoprotein complex, some of which also direct
aspects of synaptic maturation such as formation of postjunctional folds. Nicotinic receptors are also
expressed across the peripheral and central nervous system (PNS/CNS). These receptors are localized
not only at the pre- but also at the postsynaptic sites where they carry out major synaptic transmission.
In neurons, they are found as clusters at synaptic or extrasynaptic sites, suggesting that different
mechanisms might underlie this specific localization of nicotinic receptors. This review summarizes the
current knowledge about formation and stabilization of the postsynaptic apparatus at the neuromuscular
junction and extends this to explore the synaptic structures of interneuronal cholinergic synapses.
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 Abstract 
 
Fast and accurate synaptic transmission requires high-density accumulation of neurotransmitter 
receptors in the postsynaptic membrane.  During development of the neuromuscular junction, 
clustering of acetylcholine receptors (AChR) is one of the first signs of postsynaptic 
specialization and is induced by nerve-released agrin.  Recent studies have revealed that different 
mechanisms regulate assembly versus stabilization of AChR clusters and of the postsynaptic 
apparatus.  MuSK, a receptor tyrosine kinase and component of the agrin receptor, and rapsyn, an 
AChR-associated anchoring protein, play crucial roles in the postsynaptic assembly.  Once 
formed, AChR clusters and the postsynaptic membrane are stabilized by components of the 
dystrophin/utrophin glycoprotein complex, some of which also direct aspects of synaptic 
maturation such as formation of postjunctional folds.  Nicotinic receptors are also expressed 
across the peripheral and central nervous system.  These receptors are localized not only at the 
pre- but also at the postsynaptic sites where they carry out major synaptic transmission.  In 
neurons, they are found as clusters at synaptic or extrasynaptic sites, suggesting that different 
mechanisms might underlie this specific localization of nicotinic receptors.  This review 
summarizes the current knowledge about formation and stabilization of the postsynaptic apparatus 
at the neuromuscular junction and extends this to explore the synaptic structures of interneuronal 
cholinergic synapses.   
 
Index entries: Clustering; neuromuscular junction; cholinergic synapse; synaptogenesis; agrin; 
nicotinic receptors; postsynaptic density. 
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1. Introduction 
 
Synapses are the points of contact between neurons and their target cells, and mediate cellular 
communication in the nervous system.  At chemical synapses, neurotransmitter molecules are 
released from synaptic vesicles in the presynaptic nerve terminal and activate their receptors in 
the opposing postsynaptic membrane.  To ensure rapid and reliable synaptic transmission, these 
receptors must be present at a high density in clusters located precisely opposite sites of 
neurotransmitter release in the nerve ending.  Accordingly, clustering of neurotransmitter 
receptors is a key aspect of synaptogenesis and occurs early during the formation of both central 
and peripheral synapses (1). 
 Much of the current knowledge about clustering of neurotransmitter receptors originates from 
studies on the vertebrate neuromuscular junction (NMJ).  At this peripheral cholinergic synapse, 
many identified proteins interact to form a postsynaptic apparatus in the muscle, whose hallmark 
is the accumulation of nicotinic acetylcholine receptors (AChRs) in high density, reaching up to 
10,000 molecules per μm2 (1; Figure 1).  Neuronal equivalents of this postsynaptic apparatus can 
be found in synapses in the central nervous system.  One of the best-characterized examples are 
glutamatergic synapses, where the postsynaptic density contains a plethora of postsynaptic 
proteins besides glutamate receptors (2). 
Several extended reviews about the NMJ have recently appeared (1, 3-5), dealing with all 
aspects of NMJ formation, maturation and elimination.  Here, we focus largely on one key aspect 
of synaptogenesis at the NMJ, the clustering of AChRs, and show possible parallels to 
localization of neuronal nicotinic receptors at interneuronal cholinergic synapses.  Recent studies 
suggest that different proteins direct formation versus maintenance of AChR clusters and the 
postsynaptic apparatus at the NMJ.  Therefore, we divide the description of muscle AChR 
clustering into two main parts, formation versus stabilization. 
 
 
2.  The Neuromuscular Junction: Formation of AChR Clusters and the Postsynaptic 
Apparatus 
 
The high density of postsynaptic AChRs at the adult NMJ is accompanied by a 1000-fold 
lower level of extrasynaptic AChRs and is the result of three major signaling processes (1).  
During development, before motorneurons approach muscles, AChRs are diffusely distributed at 
a density of about 1000 receptors per μm2  throughout muscle fibers.  First, upon contact with the 
nerve ending, these pre-existing AChRs are redistributed to form clusters at sites of nerve-muscle 
  3
contact.  Second, muscle nuclei underneath the nerve terminal start to transcribe genes encoding 
AChRs at elevated levels.  Third, extrasynaptic nuclei cease the transcription of AChR genes. 
Together, these three processes cause the high density of AChRs in the postsynaptic membrane 
and the virtual absence of AChRs throughout the extrasynaptic plasmalemma.  In this review, we 
largely focus on the first of these processes, the clustering of AChRs. 
 
Agrin and Neuregulin Are Two Key Factors for Formation of the NMJ 
During development of the NMJ, AChR clustering is induced by agrin, a key proteoglycan 
released from the nerve (6).  Originally isolated from the electric organ of Torpedo californica 
based on its ability to cluster AChRs upon addition to cultured myotubes (6), agrin turned out to 
be the main organizer of the NMJ.  Agrin is synthesized by motorneurons, transported along their 
axons and released into the extracellular milieu, leading to accumulation in the synaptic basal 
lamina.  In its absence, in agrin-deficient knockout mice, differentiated NMJs fail to form, and 
nerve-associated clusters of AChRs and other postsynaptic proteins are no longer observed (7).  
Agrin’s crucial role in postsynaptic assembly is further illustrated in microinjected myofibers in 
vivo, where injection of agrin cDNA causes the local formation of ectopic postsynaptic 
specializations that contain clustered AChRs in association with many other postsynaptic proteins 
(8, 9).  Thus, agrin is both necessary and sufficient to induce AChR clustering and formation of 
the postsynaptic apparatus.  Finally, agrin may also play a role, perhaps indirectly, in presynaptic 
differentiation, because in agrin-deficient animals, motorneurons grow extensively over muscle 
fibers of the diaphragm without being restricted to a central endplate zone (7).  The signaling 
pathway of agrin in muscle includes the receptor tyrosine kinase (RTK) MuSK as a key element 
and will be described below. 
AChR transcription by myonuclei underneath the nerve terminal is induced at least in part by 
neuregulin-1 (NRG-1), a protein expressed by motorneurons and skeletal muscle and 
concentrated at the NMJ (3, 10).  NRG-1 is a member of the neuregulin family of differentiation 
factors and was originally isolated as ARIA (AChR-inducing activity) from chick brain extracts, 
based on its ability to induce AChR gene expression in cultured myotubes (reviewed by) (10).  As 
shown by heterozygous recombinant mice lacking one copy of the NRG-1 gene, NRG-1 is indeed 
necessary to maintain the high synaptic density of AChRs in vivo (11).  NRG-1 acts by activating 
ErbBs (ErbB2-4), members of the EGF receptor family of RTKs, which are concentrated at the 
NMJ (12, 13).  ErbB activation in turn triggers a generic signaling cascade including kinases such 
as Ras, Raf, MAP kinases and phosphatidylinositol-3-kinase, as well as the adapter protein Shc 
and the tyrosine phosphatase SHP2 (14-17).  Together, activation of these signaling intermediates 
culminates in enhanced transcription of AChR genes in synaptic nuclei.  This transcription is 
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thought to be mediated by binding of members of the ets family of transcription factors, such as 
GABPα and GABPβ, to N-box motifs in the regulatory regions of the AChR subunit genes (18, 
19).  
Interestingly, recent studies indicate that the agrin and NRG-1 signaling pathways, which both 
contribute to the high density of AChRs in the postsynaptic membrane, are linked, and that agrin 
acts upstream of NRG-1 in the formation of the NMJ.  Thus, besides clustering of pre-existing 
AChRs, agrin can induce AChR gene expression in cultured myotubes (20) and in injected 
myofibers in vivo (21, 22).  Furthermore, NRG-1 binds to agrin in vitro, and agrin-induced AChR 
gene transcription is dependent on signaling through ErbB2 in cultured myotubes (23).  As ErbBs 
are no longer clustered at mutant NMJs of mice lacking agrin (7), these observations suggest that 
agrin acts upstream of NRG-1 in postsynaptic differentiation, by inducing clustering of NRG-1 
receptors, thereby enabling NRG-1 to locally stimulate AChR gene transcription in subsynaptic 
nuclei. 
 
MuSK, a Component of the Agrin Receptor 
Despite a long-standing interest in the mechanisms of agrin signaling and postsynaptic 
assembly, many steps in agrin-induced clustering of pre-existing AChRs remain uncertain.  It is 
clear, however, that neurally-released agrin activates a receptor in the muscle membrane, which 
initiates a signaling cascade that ultimately leads to clustering and anchoring of AChRs via 
intracellular and AChR-associated signaling and anchoring proteins (1, 6).  A key component of 
the functional agrin receptor is the RTK, MuSK.  The crucial role of this RTK is best illustrated 
by MuSK-deficient mice, which lack differentiated NMJs, clusters of AChRs and other 
postsynaptic proteins, and thus display a similar phenotype as agrin -/- mice (24).  Moreover, 
cultured MuSK -/- myotubes fail to respond to agrin, whereas agrin triggers a rapid tyrosine 
phosphorylation of MuSK when added to wild-type muscle cells, further showing that MuSK is a 
part of the agrin receptor (25).  
In analogy to certain other RTKs that require co-receptors to bind to their extracellular ligands, 
MuSK itself is unable to directly bind to agrin (25).  This observation has led to the proposal that 
other proteins of myotubes (designated MASC, for myotube-associated specificity component) 
associate with MuSK to form a fully functional agrin receptor.  The nature of MASC, however, 
has remained largely elusive, although MASC most likely interacts with the first 
immunoglobulin-like domain in the extracellular part of MuSK (26).  Based on its tight binding to 
agrin, α-dystroglycan, which is a component of the dystrophin/utrophin glycoprotein complex 
(D/UGC), was originally proposed to form part of a functional agrin receptor, thus being a 
candidate for MASC.  Subsequent studies have shown, however, that agrin fragments that do not 
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bind to α-dystroglycan still induce AChR clustering and activate MuSK (27-29), and that agrin-
induced MuSK activation is normal in antisense-treated myotubes that express low levels of α-
dystroglycan (30).  Thus, α-dystroglycan does not seem to be the MASC co-receptor for MuSK.  
Another important question is how, following stimulation by agrin, MuSK transmits a signal 
into myotubes.  By analogy with other RTKs, MuSK signaling is expected to involve binding of 
signal-transducing molecules to phosphorylated tyrosine residues in the cytoplasmic domain of 
agrin-activated MuSK.  Following treatment with agrin, MuSK indeed undergoes 
autophosphorylation, probably on several cytoplasmic tyrosine residues (31).  By mutational 
analysis, two of these tyrosines were found to be required for agrin-induced AChR clustering in 
myotubes.  One tyrosine is located in the activation loop of the kinase domain, showing that the 
kinase activity of MUSK is necessary for its responsiveness to agrin (26, 32).  In addition, a 
juxtamembrane tyrosine is required as well and can, along with the sequences surrounding it, 
actually confer agrin responsiveness when expressed in otherwise inactive MuSK-TrkA chimeras 
(32).  As the juxtamembrane tyrosine occurs within an NPXY sequence context, the consensus 
binding site for Shc and related adapter proteins, one or several Shc-like proteins are likely to be 
involved as downstream mediators in the agrin signaling pathway.  
 
Rapsyn, an AChR Clustering Protein  
A central player in the agrin signaling pathway downstream of MuSK is rapsyn.  This protein 
was originally identified as a 43 kDa protein in Torpedo synaptic membranes based on its close 
association with AChRs (33).  Rapsyn is necessary for clustering of AChRs and many aspects of 
postsynaptic differentiation in muscle.  Thus, rapsyn-deficient mice lack aggregates of AChRs, 
dystroglycan, utrophin and ErbB receptors, and cultured rapsyn -/- myotubes do not form AChR 
clusters spontaneously nor even in response to agrin (34).  Because MuSK is still localized 
synaptically at mutant NMJs in these mice and is tyrosine-phosphorylated by agrin in rapsyn -/- 
myotubes, rapsyn clearly acts downstream of MuSK (35).  
The mechanism of rapsyn-dependent clustering of AChRs has been extensively analyzed by 
protein expression in heterologous cells.  In transfected non-muscle cells, rapsyn causes clustering 
of itself, and, upon co-expression, of AChRs and certain other postsynaptic proteins such as 
MuSK or dystroglycan.  This suggests that rapsyn is a general mediator of protein clustering (36-
38).  Rapsyn has a unique protein structure in which an N-terminal myristoylation site is followed 
by eight tetratricopeptide repeats (TPR), a coiled-coil motif, a ring zinc finger motif and a serine 
phosphorylation site (reviewed by 39).  By heterologous expression, some of these domains were 
found to mediate distinct aspects of rapsyn functioning.  First, N-terminal myristoylation mediates 
targeting of rapsyn to the plasma membrane (40, 41).  Second, at least two of the eight TPRs are 
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necessary and sufficient for self-association of rapsyn as clusters in transfected cells, whereas, 
third, the coiled-coil motif is required for co-clustering of AChRs in rapsyn aggregates (40, 42).  
Furthermore, rapsyn clusters each of the AChR subunits in heterologous cells and requires the 
intracellular portion of the subunit for this, as shown by the AChR α subunit (43).  Together, 
these recent studies suggest that rapsyn interacts with the cytoplasmic moieties of all subunits of 
the AChR and that rapsyn self-association and rapsyn-induced AChR clustering are mediated by 
different domains in rapsyn.  
Rapsyn also causes clustering of MuSK and dystroglycan upon co-expression in QT-6 cells, 
and biochemical evidence shows that rapsyn directly binds to the cytoplasmic portion of β-
dystroglycan (44).  In the case of MuSK, the interaction, unexpectedly, does not depend on the 
cytoplasmic tail of MuSK, but involves the fourth immunoglobulin-like domain in MuSK’s 
exodomain, leading to the concept that a rapsyn-associated transmembrane linker protein (RATL) 
links rapsyn to the exodomain of MuSK (Figure 1; 26, 35).  This linker, whose identity remains 
unsolved, may recruit rapsyn and its associated proteins to MuSK and thereby play a crucial role 
in agrin signaling.  
These results are largely based on studies performed using heterologous cell systems and may 
not be entirely applicable to myotubes, where clustering is regulated in different and/or additional 
ways: in myotubes, efficient AChR clustering requires agrin and MuSK, and the clusters are 
much larger.  In myotubes, indeed, the expression level of rapsyn is an important parameter that 
determines its ability to mediate agrin-induced AChR clustering.  Endogenous rapsyn normally 
occurs in about a 1:1 stoichiometry with the AChR in muscle (45).  Upon overexpression of 
rapsyn in wild-type or rapsyn -/- myotubes, fewer spontaneous and agrin-induced AChR clusters 
are seen than in cells expressing physiological levels of rapsyn (46, 47).  This effect appears to 
originate from intracellular accumulation of AChRs in the case of high rapsyn expression, 
implying a role of rapsyn in trafficking of AChRs to the plasma membrane (48).  Consistent with 
such a role, rapsyn was recently colocalized with AChRs in post-Golgi transport vesicles of 
Torpedo electric organ (49).  Another example illustrating the differences between heterologous 
and muscle cells is the zinc ring finger domain of rapsyn, which is dispensable for rapsyn-induced 
AChR clustering in heterologous cells but not for spontaneous AChR aggregation in myotubes 
(42, 50).  These studies suggest that in myotubes, rapsyn functioning depends on interaction with 
other, as yet unidentified muscle-specific proteins. 
 
Downstream Agrin Signaling: a Role of AChR β Phosphorylation and Src-family Kinases 
Prominent other steps in the agrin signaling pathway downstream of MuSK are tyrosine-
phosphorylation of the AChR and a link of the AChR to the cytoskeleton.  Four recent studies 
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now show that phosphorylation of the AChR β subunit and Src-family kinases play a role in these 
processes and hence for formation and stabilization of AChR clusters (51-54).  
In myotubes in culture, agrin induces tyrosine phosphorylation of the AChR β and δ subunits 
as well as a link of the AChR to the cytoskeleton, as shown by AChR extraction assays (52, 55, 
56).  Also, developing NMJs in vivo contain phosphotyrosine-proteins that codistribute with 
AChRs, and AChRs at these junctions are progressively stabilized, presumably through a link to 
cytoskeletal elements (57, 58).  In agrin-treated myotubes, AChR β and δ phosphorylation occur 
early before clusters are visible (52); β phosphorylation is paralleled by decreased extractability 
of the AChR, which also precedes clustering (55).  Several strategies have been applied to 
determine whether the AChR phosphorylation induced by agrin plays a role in AChR clustering 
and cytoskeletal linkage.  For example, inhibitors of tyrosine kinases, such as herbimycin and 
staurosporine, block both agrin-induced AChR β and δ phosphorylation and clustering (52, 56, 
59).  Conversely, increasing AChR phosphorylation by treatment of myotubes with pervanadate 
causes an increased cytoskeletal link of AChRs (60).  Most importantly, when mutated AChRs, 
lacking cytoplasmic tyrosine residues in their β subunits, are expressed in transfected myotubes, 
they are still able to form agrin-induced clusters (61), but the extent of clustering and their 
cytoskeletal linkage are clearly reduced when compared to wild-type AChRs (51).  Thus, agrin-
induced phosphorylation of the AChR β subunit regulates the link of the AChR to the 
cytoskeleton and contributes to clustering of AChRs.  
Another issue is which kinase(s) causes phosphorylation of the AChR subunits in response to 
agrin and what role such a kinase plays in agrin-induced AChR clustering.  MuSK is unlikely to 
directly phosphorylate the AChR, as illustrated in rapsyn -/- myotubes and staurosporine-treated 
wild-type myotubes, in which  agrin activates MuSK, whereas AChR β and δ phosphorylation 
and clustering are blocked (35, 52, 62).  These studies strongly imply the existence of some other 
kinase(s) downstream of MuSK.  Accumulating evidence suggests that this kinase(s) is a member 
of the Src-family: first, Src and Fyn are associated with AChRs in myotubes (63), whereas Fyn 
and Fyk are major kinases in Torpedo electric organ and associate with AChRs in this tissue (64, 
65).  Second, Src can phosphorylate AChR β fusion proteins containing the tyrosine residue that 
is phosphorylated in agrin-treated myotubes (51, 63).  Third and most importantly, AChR-bound 
Src family members are activated and tyrosine-phosphorylated in agrin-treated myotubes, and this 
activation is abolished by staurosporine and not observed in rapsyn-deficient myotubes, and thus 
correlates highly with AChR clustering (52).  Fourth, similarly, each of the Src family kinases 
Src, Fyn and Fyk can interact with rapsyn in transfected fibroblasts, leading to an activation of 
these kinases and  phosphorylation of cotransfected AChRs (66).  Fifth, Src and Fyn form a 
complex with MuSK in myotubes, are able to phosphorylate MuSK, and their binding to MuSK 
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depends on their SH2 domain and is increased by agrin (53). Sixth, of significance, in myotubes, 
the agrin-induced linkage of AChRs to the cytoskeleton is blocked by a specific inhibitor of the 
Src family, PP1, and agrin-induced AChR clustering is reduced by expression of dominant-
negative, kinase-inactive Src, resulting in AChR aggregates that are very small (53).  Finally, by 
using knockout mice, the role of Src and Fyn in postsynaptic differentiation, AChR clustering and 
phosphorylation was directly tested (54).  In mice lacking Src and Fyn, all aspects of synaptic 
development examined such as innervation, AChR gene expression and clustering of postsynaptic 
proteins are normal until around birth, by which time these animals die (54).  In cultured Src-Fyn-
deficient myotubes derived from these mice, agrin causes normal AChR clustering and AChR β 
phosphorylation, and the Src-family kinase Yes is upregulated. Interestingly, following 
withdrawal of agrin, agrin-induced clusters of AChRs are dramatically less stable in myotubes 
lacking Src and Fyn than in wild-type cells (54).  
Together, these recent studies show that kinases of the Src family play a role in agrin 
signaling: they interact with MuSK in an agrin-dependent manner and are activated by agrin 
locally, when bound to the AChR.  Further, their functioning is required to link the AChR to the 
cytoskeleton and for growth of AChR clusters.  Src and Fyn themselves, however, are dispensable 
for AChR clustering and phosphorylation, although, in their absence, Yes may compensate.  
Nonetheless, Src and Fyn are clearly required to stabilize agrin-induced AChR aggregates, 
showing that the mechanisms for formation versus stabilization of these clusters are different.  
 
Protein Interactions and Steps in Formation of the Postsynaptic Apparatus: Evidence for 
Postsynaptic Pre-assembly 
Src-family kinases interact both with MuSK and the AChR in myotubes.  In both cases, some 
interaction occurs before addition of agrin, thus revealing the existence of pre-assembled protein 
complexes.  However, these interactions appear to reflect two distinct pools of Src-family kinases 
that respond differently to treatment with agrin.  Thus, agrin causes Src members to increasingly 
bind to MuSK (53), but activates AChR-associated Src kinases without affecting their interaction 
with AChRs (52).  Furthermore, agrin induces MuSK phosphorylation independently of rapsyn 
(35), implying that Src-mediated MuSK phosphorylation (53) does not require rapsyn.  In 
contrast, activation of AChR-bound Src members by agrin critically depends on rapsyn (52).  
Therefore, there is increasing evidence for the existence of two independent pre-assembled 
signaling complexes in myotubes, a MuSK-bound complex and an AChR-bound complex (Figure 
2).  
How do these complexes contribute to postsynaptic assembly?  The available evidence 
suggests that the MuSK-bound complex acts as a primary synaptic scaffold and is clustered first 
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due to agrin; this scaffold then recruits pre-assembled AChR complexes via rapsyn (Figure 2).  
These steps of postsynaptic assembly are based, first, on the observation that MuSK is the only 
identified postsynaptic protein to still be clustered at mutant synapses of rapsyn-deficient mice 
(35).  In addition, when expressed ectopically in injected muscle fibers in vivo, a constitutively 
active form of MuSK is able to organize postsynaptic specializations containing AChRs in 
association with most other postsynaptic components (67).  Second, rapsyn induces aggregation 
of AChRs, dystroglycan, MuSK and of itself when expressed in heterologous cells (36-38), 
suggesting that rapsyn recruits other postsynaptic components to the MuSK scaffold.  Third, in 
cultured myotubes, AChRs interact with rapsyn, MuSK, Src-family kinases, dystroglycan and 
utrophin independently of agrin, showing that diffusely distributed AChRs can pre-assemble 
pools of postsynaptic components including rapsyn (68).  Such complexes associate with MuSK - 
presumably  the MuSK primary synaptic scaffold - in response to agrin, leading to a rapsyn-
dependent increase in the AChR-MuSK interaction, whereas other AChR-protein interactions are 
not affected by agrin (Figure 2; 68).  Fourth, intracellular AChRs of Torpedo electric organ are 
colocalized with rapsyn, dystroglycan and syntrophin in post-Golgi transport vesicles, implying 
that some formation of pre-assembled AChR complexes may occur intracellularly (69). 
Taken together, these studies imply an active functional role of AChRs in synaptic assembly.  
Consistent with this idea, agrin does not induce clusters of acetylcholinesterase in myotubes 
where AChRs were downregulated with anti-AChR antibodies (70).  Further, agrin-induced 
clustering of a full set of postsynaptic markers requires the presence of AChRs in myotubes, as 
shown recently in derivatives of C2 myotubes expressing low levels of AChRs, as well as by 
using C2 myotubes in which surface AChRs were downregulated by anti-AChR antibodies (71; 
P.A. Marangi and C. Fuhrer, unpublished observations).  In particular, after downregulating 
AChRs by treating with antibodies, clusters of rapsyn were not produced in response to agrin 
(P.A. Marangi and C. Fuhrer, unpublished observations).  Thus, accumulating evidence suggests 
that AChRs play an active and early role in postsynaptic assembly, at least in part by forming 
complexes with other postsynaptic components, which are preassembled prior to the treatment of 
agrin (Figure 2). 
 
Other Signaling Intermediates in Agrin-induced AChR Clustering: Calcium, GTPases and 
nNOS 
Agrin-induced postsynaptic assembly (Figure 2) is likely to be regulated by additional 
signaling intermediates.  Calcium fluxes are required for AChR clustering, as shown by inhibition 
of agrin-induced AChR clustering by the fast calcium chelator, BAPTA-AM (72).  Furthermore, 
Rac and Cdc42 are necessary for agrin-induced clustering of AChRs in myotubes, because 
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dominant-negative forms of these small GTPases inhibit aggregation of AChRs in transfected 
myotubes (73).  Rac and Cdc42 are known from other systems to control actin polymerization, for 
example, causing focal reorganization of the actin cytoskeleton in response to extracellular cues.  
Indeed, latrunculin A inhibits agrin-induced AChR clustering in cultured Xenopus muscle cells, 
confirming the importance of F-actin assembly in AChR aggregation (74).  It is unclear, however, 
how F-actin acts in AChR clustering.  A synaptic component of the D/UGC, utrophin, binds to 
actin but is dispensable for AChR clustering (75), implying that actin acts through other binding 
proteins. 
Another signaling mediator that was recently recognized to play a role in agrin-induced AChR 
aggregation is nitric oxide, NO (76).  Neuronal nitric oxide synthetase, nNOS, was known for 
several years to be concentrated at NMJs, through binding to isoforms of syntrophin, components 
of the D/UGC (1).  Recently, nNOS was found to be co-clustered with AChRs in agrin-treated 
cultured myotubes (77), and NO was identified as a downstream mediator in agrin-induced AChR 
clustering and AChR β phosphorylation, as shown by using NOS inhibitors and NO donors (76).  
The targets of NO could, in principle, involve Src family kinases, as these are activated by NO in 
fibroblasts; this idea is attractive because of the activation of Src-family kinases by agrin in 
myotubes and their role in stabilization of AChR clusters (52, 54). 
 
AChR Clustering by Laminin 
Besides agrin, a number of other factors stimulate AChR clustering when added to cultured 
muscle cells.  These include laminin (78, 79) and VVA-B4, a lectin that binds synapse-specific 
carbohydrates (80).  In addition, basic fibroblast growth factor and heparin-binding growth 
associated molecule are also active in clustering when bound to polystyrene beads (81, 82).  The 
relevance of many of these factors for AChR clustering and NMJ development in vivo is unclear.  
However, laminin is of particular interest, as it is present synaptically throughout formation of the 
NMJ and colocalizes with AChR clusters both in vivo and in vitro (83), suggesting that laminin 
may provide a supplemental pathway for AChR clustering besides agrin.  In the adult, laminin is a 
major component of the muscle fiber basal lamina, with distinct synaptic and extrasynaptic 
isoforms.  Laminin molecules are heterotrimers composed of three chains, α, β and γ, which exist 
in multiple forms encoded by separate genes, giving raise to many laminin isoforms.  The basal 
lamina at mature NMJs contains three major laminin forms, laminin-4 (α2β2γ1), laminin-9 
(α4β2γ1), and laminin-11 (α5β2γ1) (Figure 1), whereas laminin-2 (α2β1γ1) is the predominant 
extrasynaptic isoform found in adult muscle and transiently present at developing NMJs (84).  
Laminin-1 (α1β1γ1), in turn, is expressed early in skeletal muscle development and around the 
time of initial synapse formation.  A crucial role in neuromuscular synaptogenesis has been 
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shown for the β2 chain.  In β2-deficient mice, synaptic organization is aberrant: postsynaptic 
folds are reduced, the number of active zones in the nerve terminal is decreased, and Schwann 
cells extend processes into the synaptic cleft (85).  Schwann cell intrusion originates from the 
absence of laminin-11, which normally prevents Schwann cell entry by inhibiting growth of their 
processes (86).  
Binding of agrin to laminin appears to form the basis for the localization and tight association 
of agrin with the muscle basal lamina.  The N-terminal portion of the major isoform of agrin in 
the PNS, designated as the NtA domain (87, 88), binds with high affinity to laminin-1, -2, and 
particularly well to the synaptic laminin-4 (89).  Binding occurs through the coiled coil domain of 
the γ1 chain (90, 91).  This binding may thus contribute to synaptic localization of agrin and 
suggests that both laminin and agrin act together in synaptic development.  
Laminin-1 and merosin (laminin-2/4) cluster AChRs when added to cultured myotubes (78, 
79, 92).  The laminin signaling pathway is different from that of agrin and does not involve 
MuSK or tyrosine phosphorylation of AChRs (78, 79).  Laminin-induced AChR clustering occurs 
with a slower time-course and leads to higher densities of AChRs in clusters than in the case of 
agrin.  Moreover, the laminin clustering pathway involves dystroglycan, as shown both in 
antisense myotube derivatives expressing very low amounts of dystroglycan and in myotubes 
differentiated from dystroglycan -/- embryonic stem cells, where laminin fails to cause AChR 
aggregation (78, 93).  Laminin signaling may also involve integrins, because α7β1 integrins are 
coclustered with AChRs in response to laminin, and as anti-α7 antibodies modulate the AChR 
clustering ability of laminin (Figure 1; 94).  This is consistent with the postsynaptic localization 
of several forms of these receptors at endplates, in particular, α3, α7, αv and β1 (5).  
Interestingly, integrins are also suggested to act as modulators in agrin signaling, in particular, the 
αvβ1 heterodimer (95), based on antibody inhibition experiments.  In addition, cells 
overexpressing αv and β1 integrin adhere to agrin, revealing a possible binding of agrin to this 
particular integrin.  
Thus, integrins, in particular those containing β1, appear to be involved in laminin as well as 
agrin signaling.  Accordingly, besides their differences, agrin and laminin share some of their 
signaling mechanisms, explaining the additive effects of agrin and laminin on AChR clustering in 
myotubes (79).  Together, these studies indicate that agrin and laminin can act in concert to lead 
to maximal AChR clustering, which may be important for postsynaptic differentiation at the NMJ 
in vivo. 
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Role of Oligosaccharides in AChR Clustering 
Carbohydrates that terminate in N-acetyl-galactosamine (βGalNAc) are selectively enriched at 
the NMJ and react with specific lectins such as VVA-B4 (80).  Recent studies have shown that 
several factors that bind to and/or modify oligosaccharides, preferentially complex-type N-linked 
sugars, can induce AChR clustering in cultured myotubes, thus raising the possibility that such 
oligosaccharides contribute to AChR aggregation during formation of the NMJ in vivo.  These 
factors include VVA-B4, neuraminidase and α-galactosidase (80, 96, 97).  While VVA-B4 acts 
via a pathway independent of MuSK and AChR phosphorylation, possibly via α-dystroglycan 
(98), neuraminidase increases MuSK and AChR phosphorylation, indicating that oligosaccharides 
may be involved both in agrin-dependent and agrin-independent mechanisms of AChR clustering.  
Of particular interest are VVA-B4-reactive sugars containing βGalNAc.  At the NMJ, βGalNAc 
occurs in the context of a defined oligosaccharide structure, the CT carbohydrate antigen, which 
contains the disaccharides Galβ1,3GalNAc and Galβ1,4GlcNAc as prominent components (99).  
Both of these disaccharides induce AChR clustering in myotubes as well as MuSK 
autophosphorylation in vitro, as shown by in vitro phosphorylation assays (99).  Interestingly, 
agrin contains a mucin-like domain to which lactosamine-like saccharides are attached.  
Fragments of agrin containing the mucin domain stimulate MuSK autophosphorylation in vitro, 
which can be inhibited by adding Galβ1,3GalNAc or Galβ1,4GlcNAc. Finally, these 
disaccharides bind to agrin and MuSK in vitro (99).  
The CT antigen thus can serve a similar function to that proposed for the MuSK co-receptor 
MASC, since it can bind to agrin and MuSK, and stimulate the MuSK kinase activity.  Therefore, 
the CT carbohydrate may act as MASC.  It remains to be determined on which protein the active 
CT carbohydrates are present, and which protein(s) are recognized by VVA-B4 at NMJs in vivo.  
 
 
3.  Stabilization of AChR Clusters and Maturation of the Postsynaptic Apparatus 
 
During development of the NMJ, AChR clusters are formed rapidly after contact between 
motorneuron and muscle.  At birth, clustered AChRs are homogenously arranged in a flat 
postsynaptic membrane underneath the nerve, muscle fibers are multiply innervated, and several 
nerve terminals are intermingled over the postsynaptic apparatus (1).  In the first weeks of 
postnatal development, competitive mechanisms between these motorneurons lead to synapse 
elimination.  Another aspect of postnatal maturation is the formation of postjunctional folds, 
leading to segregation of some proteins to become concentrated either at the crests or in the 
troughs of these folds.  AChRs, for example, are localized at the crests, whereas sodium channels 
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are located in the troughs.  Using knock-out mice, recent studies indicate that components of the 
D/UGC, while largely dispensable for initial AChR clustering, are essential both for consolidation 
and stabilization of AChR clusters as well as for formation of postjunctional folds. 
 
The D/UGC is Required for Stabilization of AChR Clusters and Postnatal Maturation of the 
Postsynaptic Membrane 
The D/UGC links the cytoskeleton of muscle fibers to their extracellular matrix and thereby 
stabilizes the muscle sarcolemma (100).  Differential localization of members of the complex 
gives rise to synaptic and extrasynaptic variants of the D/UGC.  At NMJs, utrophin, β2-
syntrophin and α-dystrobrevin-1 are highly concentrated and virtually absent from extrasynaptic 
areas, whereas α-syntrophin, α-dystrobrevin-2, α- and β-dystroglycan and dystrophin are found 
both at NMJs and extrasynaptic areas (38, 101, 102).  Additional components of the complex, the 
sarcoglycans and sarcospan, are found synaptically and extrasynaptically as well (100).  
Extracellular binding partners for the synaptic D/UGC are agrin and laminin isoforms (laminin 
chains β2, α5 and α4), which are all concentrated at NMJs (Figure 1).  The largest components of 
the D/UGC, utrophin and dystrophin, are necessary for the integrity of muscle fibers but largely 
dispensable for NMJ formation.  Utrophin-deficient mice have a surprisingly mild phenotype in 
that they appear healthy and viable, and have functional NMJs (75, 103).  The density of synaptic 
AChRs is slightly reduced, and formation of postjunctional folds after birth is less pronounced.  
Likewise, NMJs of mdx mice, which lack functional dystrophin, are largely normal, apart from a 
reduced number of postsynaptic folds.  This reduction may result from muscle fiber necrosis and 
cycles of regeneration rather than from the absence of dystrophin per se (104, 105).  These 
relatively minor effects on morphology of the NMJ in utrophin-/- and mdx mice could, in 
principle, be due to partial compensation between the two proteins.  Accordingly, double-
deficient mice lacking both dystrophin and utrophin develop a severe muscular dystrophy closely 
resembling human Duchenne muscular dystrophy (106, 107).  However, even in these animals, 
NMJs are remarkably normal, displaying subtle postsynaptic defects such as reduced AChR 
density and less postsynaptic folds.  This suggests that the D/UGC as such is not essential for 
formation of the NMJ and AChR clusters, but rather for their maturation, in particular, formation 
of postsynaptic folds.  
A component of the D/UGC involved in consolidation and maintenance of AChR clusters and 
the NMJ is dystroglycan (Table I).  As dystroglycan-deficient mice die at E6.5, before muscles 
are formed, chimaeric mice were generated by injecting dystroglycan -/- embryonic stem cells 
into blastocytes of wild-type; these chimeras lack dystroglycan in many striated muscles (108).  
Dystroglycan-deficient muscles of these mice develop severe muscular dystrophy and, in adult 
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animals, NMJs are fragmented and lack the typical high density of AChRs and AChEsterase. 
Instead, AChRs are distributed over an increased area, with a coordinate increase in nerve 
terminal size at these junctions (93).  Agrin-induced AChR clustering was analyzed by using 
myotubes generated from dystroglycan -/- embryonic stem cells.  Agrin still induces substantial 
AChR clustering in these cells, but utrophin, α-dystrobrevin, laminin chains, perlecan and 
AChEsterase are not found at these clusters (93, 109).  As in vivo in chimaeric mice, the area of 
agrin-induced AChR clusters is increased in dystroglycan -/- myotubes, and the clusters actually 
consist of many microclusters and disperse rapidly after withdrawal of agrin.  Similarly, 
formation of AChR clusters of normal size is severely compromised in antisense derivatives of 
C2 myotubes expressing low amounts of dystroglycan (30).  As phosphorylation of MuSK and 
AChR β subunits is unchanged in these antisense cell lines, dystroglycan and the D/UGC as such 
are not necessary for AChR clustering per se, and dystroglycan is not a coreceptor for MuSK. 
Overexpression of dystroglycan can decrease AChR clustering at developing Xenopus NMJs, 
however, most likely by adsorbing agrin and preventing it form normal signaling via MuSK 
(110).  Together, these data indicate that dystroglycan is required for integrity of the D/UGC and 
serves as a membrane anchor to recruit components of the complex to the plasma membrane.  
Furthermore, dystroglycan is required for consolidation of AChR microclusters into clusters of 
normal size and for stabilization of AChR aggregates and the NMJ.  
Similarly, α-dystrobrevin isoforms are necessary to stabilize AChR clusters (Table I).  Mice 
deficient for α-dystrobrevin develop muscular dystrophy due to the absence of D/UGC-linked 
signaling by nNOS, which normally binds to dystrobrevin (111).  At the NMJ of these animals, 
initial synapse formation proceeds relatively normally, but postnatal maturation is affected, 
because less postsynaptic folds are formed and contain AChRs at crests as well as in troughs, and 
because AChR-rich areas become fragmented in older animals (109).  Synaptic localization of 
dystrobrevin-binding proteins such as α- and β2-syntrophin or nNOS, but not other D/UGC 
components, is reduced in the mutants.  Finally, in cultured myotubes, agrin induces normal 
clustering of AChRs, but these clusters disperse rapidly upon withdrawal of agrin (109).  
Dystrobrevin is thus necessary for stabilization of AChR clusters in vitro and in vivo and for 
formation of postsynaptic folds with characteristic segregation of AChRs between crests and 
troughs.  As NMJs in triple knockout mice lacking utrophin, dystrophin and α-dystrobrevin are 
not dramatically different from single dystrobrevin knockouts (109), essential synaptic functions 
of the D/UGC seem to be mediated by dystrobrevin, probably by localizing its associated 
signaling molecules to the NMJ.  
Finally, absence of α-syntrophin leads to structurally aberrant synapses (112).  The isoforms of 
syntrophin show differential localization at the adult NMJ.  Whereas α-syntrophin is found at the 
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crests and in the troughs of postsynaptic folds, β2-syntrophin occurs mainly in the troughs; the β1 
isoform is not concentrated at the NMJ (102).  In the absence of α-syntrophin, muscle fibers 
appear healthy histologically and the mice are mobile and fertile (113).  NMJs of these animals 
lack utrophin and nNOS, have reduced levels of AChRs and AChEsterase and show abnormal 
postsynaptic folds with fewer openings to the synaptic cleft (112).  α-syntrophin thus mediates 
localization of utrophin and nNOS to the NMJ, and the similarities in NMJs between α-
syntrophin- and utrophin-deficient mice suggest that α-syntrophin functions to localize utrophin 
at the synapse, which organizes postsynaptic fold formation.  
Together, studies on knockouts of components of the D/UGC show that this complex is largely 
dispensable for initial formation of AChR clusters and the NMJ.  Instead, the complex is mainly 
required for postnatal maturation of the postsynaptic membrane as well as for stabilization of 
AChR clusters.  
 
Tyrosine Kinases Are Required for Stabilization of Agrin-induced AChR Clusters 
Three lines of evidence have recently indicated that, in addition to the D/UGC, tyrosine 
kinases are important for the stability of agrin-induced AChR clusters.  First, upon removal of 
agrin, the kinase inhibitors herbimycin and staurosporine disperse pre-formed AChR clusters in 
myotubes (56), showing that tyrosine kinase activity is necessary to maintain AChR clusters.  
This activity most likely originates from another kinase than MuSK, because staurosporine does 
not affect the autophosphorylation of MuSK (62).   
Second, Src and Fyn mediate stabilization of AChR clusters, because in myotubes cultured 
from Src-Fyn-doubly deficient mice, agrin induces normal phosphorylation and aggregation of 
AChRs, but these clusters disperse rapidly after withdrawal of agrin (54).  Src and Fyn are thus 
dispensable for AChR clustering, but essential for cluster stabilization. PP1 and PP2, inhibitors of 
Src-family kinases, do not decrease the stability of AChR aggregates, suggesting that cluster 
stabilization does not primarily require the kinase activities of Src and Fyn, but rather their 
presence as adapters, by mediating protein interactions (54; Table I).  These findings reveal 
interesting parallels to focal adhesion sites, where Src, independent of its kinase activity, can 
recruit and activate other proteins such as focal adhesion kinase (FAK) (114, 115).  Furthermore, 
multiple tyrosine kinases, including Src, FAK and Pyk2, can complement each other to achieve 
optimal adhesion on fibronectin (116), raising the possibility that interaction of multiple kinases 
may regulate interactions between the postsynaptic membrane and cytoskeleton elements at the 
NMJ, thereby stabilizing AChR clusters.  In support of this, several cytoskeletal proteins such as 
talin, paxillin and α-fodrin can be tyrosine-phosphorylated and are concentrated at the 
mammalian NMJ or in Torpedo synaptic membranes (117).  
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Third, TrkB is also involved in cluster stabilization.  Disruption of TrkB-mediated signaling, 
by overexpression of a dominant-negative form of TrkB, decreases the stability of AChR clusters 
in vivo and in agrin-treated cultured myotubes (Table I; 118).  TrkB is localized to the 
postsynaptic membrane in muscle and can associate with Fyn in cortical neurons (118, 119), 
raising the possibility that TrkB signaling mediated by Src-family kinases stabilizes AChR 
clusters in muscle.  The ligand for TrkB mediating this effect is not known.  BDNF, a prominent 
ligand of TrkB, and  NT-4 inhibit agrin-induced AChR clustering in cultured myotubes (120).  
TrkB may thus exert two different effects at the NMJ, depending on the stage of NMJ 
differentiation.  Early in postsynaptic assembly, it may – stimulated by BDNF – negatively 
regulate AChR clustering, while later it stabilizes the postsynaptic membrane.  
Together, these studies show that several tyrosine kinases, at least Src, Fyn and TrkB, are 
involved in stabilization of AChR clusters.  The mechanisms for formation versus stabilization of 
AChR clusters are thus different, both in terms of structural proteins, as reflected by the D/UGC, 
as well as in their requirement for signaling proteins, as shown in the case of Src, Fyn and TrkB.  
It remains to be determined whether and how tyrosine kinases and the D/UGC collaborate to 
achieve optimal stabilization.  One possible link is dystrobrevin, which is a substrate for tyrosine 
kinases and strongly tyrosine-phosphorylated in Torpedo electric organ (121).  Although α-
dystrobrevin is neither required for early steps in agrin-induced AChR clustering nor tyrosine-
phosphorylated by agrin stimulation (101), its phosphorylation may play a role in stabilization of 
AChR clusters at the developing NMJ.  This would be consistent with the striking similarity in 
dispersal of AChR clusters in dystrobrevin -/- and Src-Fyn-deficient myotubes, as well as in 
muscle cells overexpressing dominant-negative TrkB (Table I).  
 
A Role of AChRs in Postsynaptic Stabilization 
During postnatal NMJ development, the composition of AChRs changes, as the embryonic γ 
subunit is replaced by the adult ε chain.  By deleting the ε gene in mouse, the role of AChRs in 
this phase of NMJ development was analyzed.  In ε -/- mice, the high postsynaptic density of 
AChRs is gradually reduced in the first weeks after birth, as these animals fail to synthesize adult-
type AChRs (122, 123).  Consequently, the mice develop gradual muscle weakness and atrophy, 
and die prematurely.  Along with the reduced AChR density, postjunctional folds disappear, in 
such a way that the postsynaptic membrane, although rich in folds at 20 days, is flattened out by 
60 days of age (124).  Further, postsynaptic components such as rapsyn, utrophin, MuSK, erbB4, 
phosphotyrosine and dystrobrevin are reduced as the AChR density decreases (122, 124).  
Interestingly, rapsyn disappears strictly in parallel with AChRs, while utrophin and dystrobrevin 
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lag behind (124).  Thus, ε-containing AChRs are required for synaptic localization of rapsyn and 
maintenance of the postsynaptic apparatus at the postnatal NMJ, including postjunctional folds.   
In addition, activity through the AChR is necessary to maintain its high synaptic density (125).  
In adult mice, AChRs are highly metabolically stabilized, displaying a half-life of about 14 days.  
Immediately after blocking AChRs by α-bungarotoxin (BTX), the half-life is reduced to less than 
a day, resulting in rapid turnover of postsynaptic AChRs and a decrease in the density of 
postsynaptic AChRs.  This decrease in half-life can be stopped by direct stimulation of muscle or 
restoration of synaptic transmission (125).  These data indicate that AChR activation is required 
for its synaptic stability and that AChRs serve structural roles in maintaining the postsynaptic 
apparatus.  AChRs thus appear to be necessary for both formation and maintenance of the 
postsynaptic apparatus at the NMJ. 
 
 
4.  Nicotinic Receptors in the Nervous System 
 
Multiple neurotransmitter receptors localized at the synapse of a neuron and different setup of 
synaptic excitability of target cells suggest that synaptic features, which have been characterized 
in the muscle, might not simply be translated into the nervous system.  Differently from the 
muscle type, nicotinic receptors in the nervous system are characterized by high Ca2+ 
permeability and considerable diversity of their subunits.  So far, nine different α  
(α2,3,4,5,6,7,8,9,10) and three different β subunits (β2,3,4) have been identified in vertebrates, 
which are encoded by distinct genes (126-128).  Differential splicing of some of the genes further 
extends this already existing list of clones (129).    
  Functional subtypes of receptors that can be generated from different arrays of subunits are 
equally diverse although they all appear to form a pentameric structure (127, 130).  α7, α8 and α9 
subunits form a homo-oligomeric complex when expressed as a single subunit and comprise the 
α-bungarotoxin (BTX)-binding class of AChRs.  The α7 subunit is one of the most abundant 
subunits that are expressed in the vertebrate nervous system and α7 receptors are characterized by 
high Ca2+ permeability that is comparable to NMDA receptor channels (131, 132).  Other 
subunits require α or β to be functional as a hetero-oligomer.  Prominent examples are α4β2, 
which is the most abundant subtype in the brain and forms high affinity nicotine binding sites, 
and ganglionic subtypes of receptors containing α3, α5, β2 and β4.  Expression of multiple 
subunit genes in the same neuronal population suggests that, in reality, the profile of subtypes of 
neuronal receptors is much more complex (126, 133, 134). 
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Mechanisms of cholinergic synaptogenesis in the nervous system are largely elusive compared 
to the NMJ and have been mainly investigated in the PNS.  Studies about the CNS synapses have 
been limited, mainly due to the relatively low expression level of nicotinic receptors in limited 
areas of the CNS.  Thus, compared to other receptor systems, very little information is available 
about how interneuronal cholinergic synapses in the CNS are built up and maintained.  In the 
following parts, studies which have been made so far for characterizing nicotinic synapses in the 
PNS and CNS are summarized, and we attempt to postulate  postsynaptic components of these 
synapses, mainly based on the information about the molecules identified at the NMJ. 
 
 
5.  Cholinergic Synapses in the Peripheral Nervous System 
 
Functional cholinergic synapses have been identified in a number of peripheral neurons from 
various species, e.g. superior cervical, ciliary and sympathetic ganglia (135-137).  In the PNS, 
nicotinic receptors mediate excitatory synaptic transmission as major neurotransmitter receptors, 
although a presynaptic function, regulating the release of neurotransmitters, has also been 
demonstrated (134, 138).  
Postsynaptic structures and functional aspects of interneuronal cholinergic synapses are best-
characterized in chick ciliary ganglia where developmental and innervation profiles have been 
well investigated.  Chick ciliary ganglion neurons express α3, α5, β2, β4 and α7 subunits and, 
thus far, two major subtypes of receptors differing in their subunit-compositions and also 
functional properties have been identified, that is, the α-BTX sensitive component comprised of 
α7 subunits and mAb35-immunoreactive receptors of which at least two classes exist depending 
on the presence of β2 subunits, e.g. α3α5β2β4 and α3α5β4 (139-141).  In the chick ciliary 
ganglion, α7 and mAb35-AChRs show interesting differences in their localizations with respect 
to synaptic sites.  Whereas clusters of α3/α5 subunit-containing ganglionic receptors are found at 
extrasynaptic sites in addition to postsynaptic densities, those of α7-containing receptors that 
represent the most abundant population of ganglionic receptors, are exclusively localized on 
perisynaptic somatic spines (135, 142).  By ultrastructural analysis, synaptic mAb35-AChRs were 
localized to the postsynaptic density (PSD) opposing presynaptic vesicle release sites.  
Perisynaptic α7 receptors on spines, interestingly, are present in close proximity to the potential 
release sites overlaid with vesicles (142, 143).  Although α7 subunits are excluded from the 
synapse, they carry majority of the synaptic current and it appears that they are important for 
rapid and reliable synaptic firing (144, 145).   
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What mechanisms could be involved in anchoring/targeting of these receptors at their 
respective sites?  Recent studies show that in chick ciliary ganglia actin filaments are colocalized 
with α7 receptors and are active components for maintaining α7 receptor-clusters in the 
postsynaptic membrane, since depolymerization of actin filaments disperses these clusters and 
also accelerates agonist-challenged rundown of the α7 channel function (142, 146).  In addition to 
association, either directly or indirectly, with f-actin, anchoring perisynaptic α7 receptors on 
somatic spines appears to involve other mechanisms, since these receptors are resistant to 
extraction by nonionic detergents even after treatment with actin-depolymerizing agents (142).  A 
recent study has demonstrated that α7 receptor clusters are tightly linked to membrane lipid rafts.  
As shown by treatments that disperse rafts, the integrity of these rafts is required to maintain α7 
clusters, independently of f-actin, thus offering an explanation for an additional anchoring 
mechanism (147).  Lipid rafts are rich in Src-family kinases and other signaling molecules (148).  
This suggests that Src and Fyn might play a role in maintaining α7 clusters and this could be an 
interesting parallel to the NMJ where these kinases are necessary to maintain AChR clusters (54).  
In contrast, ganglionic mAb35-reactive receptors, although partly found on somatic spines along 
with α7, appear to require different mechanisms for localization in the plasma membrane since 
their functional integrity is not affected by repeated applications of nicotine and they are also 
readily solubilized by nonionic detergents (142, 146).  These receptors are targeted to the 
postsynaptic density by a signal in the cytoplasmic portion of the α3 subunit: studies using 
chimeric receptor constructs showed that the cytoplasmic loop of the α3 subunit mediates 
postsynaptic localization, whereas the corresponding region of α5 lacks such targeting 
information (149).  Another candidate for localization of neuronal AChRs is rapsyn, based on its 
importance at the NMJ.  Although rapsyn causes clustering and detergent-insolubility of various 
nicotinic receptors upon expression in heterologous fibroblasts, it is not required for clustering of 
ganglionic AChRs in the superior cervical ganglion neurons, as shown in rapsyn -/- mice (see 
below, 137).  Further, although mRNA is present, postsynaptic rapsyn immunoreactivity was not 
detected in this ganglion nor in chick ciliary ganglia, indicating that rapsyn might play a different 
role, if any at all, in the nervous system.   
Another complexity of interneuronal cholinergic synapses originates from the presence of 
glycine receptor-microdomains that are associated with the postsynaptic densities of chick ciliary 
neurons (143).  Chick gephyrin specifically colocalizes with these glycine receptors, but not with 
mAb35-reactive AChRs.  Segregation of different neurotransmitter receptors and different 
subtypes of receptors  into mosaics of domains, using cognate clustering/anchoring molecules, 
thus, may be another mechanism for the neuron to fine-tune synaptic transmission. 
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Finally, extrasynaptic clusters of nicotinic receptors, in addition to clustering at the 
postsynaptic sites, have also been observed in the mouse superior cervical ganglion and the frog 
cardiac ganglion (137, 150), which raises the possibility that nonsynaptic localization of nicotinic 
receptors, yet taking part in a significant portion of synaptic transmission, might be a general 
feature of peripheral nicotinic synapses.  Although NMDA receptors in cultured hippocampal 
cells were found clustered extrasynaptically in early neuronal development, molecular 
explanations have not been provided.  Further, clustering of ligand-gated ion channel receptors 
outside of postsynaptic sites in mature neurons has not been ubiquitously found and investigated 
(151). 
 
 
6. Cholinergic Synapses in the Central Nervous System-an Overview 
 
Autoradiographic and subunit mapping studies using various ligands, antibodies and cRNA 
probes generated useful information about the distribution of nicotinic receptors and cholinergic 
synapses in the CNS (130).  Although these studies implicated cholinergic functions in the brain, 
unequivocal identification of cholinergic synapses carrying nicotinic receptors as the mediator of 
major synaptic transmission turned out to be difficult and has been limited to few examples (152).  
This has been attributed to the presynaptic role of nicotinic receptors as a primary function and 
examples are well documented by numerous studies where presynaptic functions are shared by a 
variety of neurotransmitters, e.g. glutamate, dopamine, GABA, noradrenaline and ACh, itself 
(134).  Since then, a collection of recently made studies, mostly using immunocytochemical and 
refined-electrophysiological analysis, has generated accumulating evidence for the postsynaptic 
cholinergic function, indicating that nicotinic receptors can act as the major carrier of synaptic 
current.  In the following section, studies that provided direct or indirect evidence for the role of 
nicotinic receptors in mediating rapid synaptic transmission are summarized and discussed. 
 
Immunocytochemical Characterization of Cholinergic Synapses 
α7, α4 and β2 subunits are widely expressed species of subunits in the brain, while expression 
profiles of other subunits are more limited (153-155).  Some of the areas where these subunits are 
abundantly expressed served as good model system for investigating postsynaptic aspects of 
cholinergic synapses.  However, a number of neurons express multiple subunits simultaneously 
and the question of how these are organized as synaptic responsive elements at the synapse is 
elusive and remains to be investigated. 
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Strong α4 immunoreactivity has been mapped to tyrosine hydroxylase (TH)-positive 
dopaminergic neurons in substantia nigra pars compacta (SNpc) and ventral tegmental area, of 
which cell bodies and dendrites are innervated by neurons from pedunculopontine tegmental 
nuclei (PPN) and the laterodorsal tegmental nucleus (156-158).  Postsynaptic nicotinic responses 
that can be evoked by stimulating inputs from PPN and also excitability of dopaminergic neurons 
in SNpc by application of nicotine indicate that nicotinic receptors directly mediate synaptic 
transmission in these neurons (159, 160).  Dopaminergic neurons express multiple nicotinic 
subunits and studies from different lines suggest that the α4β2 combination of receptors among 
others are likely candidates for functional nicotinic receptors mediating fast synaptic transmission 
(161-164).  Light microscopic and ultrastructural analysis revealed some features of subcellular 
distribution of α4 subunits.  α4- immunoreactivity was associated with cell perikarya and 
dendritic shafts, but not with spines (158, 160).  Labeling of some postsynaptic structures was 
evident as assessed by electron microscopic analysis, but some nonsynaptic labeling was also 
identified.  Further, a detailed study using postembedding immunogold procedures demonstrated 
clear labeling of α4 at the PSD although the frequency of the labeling was low (158). 
So far, studies that demonstrated association of nicotinic receptor subunits with the PSD in the 
CNS have been limited to α4 subunits.  Although α4 subunits decorate the PSD at very low 
frequency in dopaminergic neurons of the substantia nigra, PSD association has been 
demonstrated more convincingly in other brain areas such as the paraventricular nucleus of the 
hypothalamus and pyramidal cells in layer 5 of the rat cortex (165, 166).  The common theme 
arising from these studies is the distribution of α4 subunits in the cell body and proximal rather 
than distal parts of dendrites.  It is notable that β2 subunits, which preferentially assemble with α4 
subunits and form high affinity nicotine binding sites, also exclusively label perikarya with rare 
synaptic labeling in the brain as judged by electron microscopic analysis (154). 
Another example for fast synaptic nicotinic responses is found in the chick lateral spiriform 
nucleus (SpL) that receives cholinergic projections from the nucleus semilunaris.  Nicotinic 
synapses have been identified by the double-label immunofluorescence technique using 
antibodies to choline acetyltransferase (ChAT) and mAb35 (167).  ChAT–positive 
immunoreactivity was associated with that of mAb35 more preferentially in the fibers lateral to 
SpL than in neurons in the nucleus, and colocalization was pronounced in dendrites but not on the 
neuronal soma of these neurons.  The clusters of mAb35-immunoreactive nicotinic receptors were 
not frequently colocalized with presynaptic vesicle markers, suggesting that most of clusters are 
of non-synaptic origins (168).  However, stimulation of cholinergic afferents to SpL neurons 
generated nicotinic excitatory postsynaptic potentials (EPSPs) that can evoke action potentials 
(167).  These responses were not sensitive to antagonists for α7 receptors and might be mediated 
  22
by α5,β2 subunit-containing receptors since they are expressed by more than 90% of the neurons 
in the SpL (168).  Thus, nicotinic receptors in SpL neurons are primarily concentrated at 
extrasynaptic sites, and yet they participate in eliciting the postsynaptic response. 
α7 subunits that constitute α-BTX binding sites are enriched in the hippocampus and some 
nuclei of the brain stem (155, 161).  Morphological analysis suggests postsynaptic roles of these 
receptors since there was no significant axon terminal staining.  The subcellular staining pattern 
of α7 varied across different neuronal groups in terms of the extent of dendritic labeling, since all 
dendritic trees were labeled in some cases and, in others, only very proximal portion of dendrites 
were labeled.  Even with frequent labeling across the brain, functional α7 receptors mediating fast 
synaptic transmission have been conclusively identified only in interneurons of the hippocampus 
(see below).  Differently from the PNS, clustered postsynaptic patch type of immunostaining was 
not observed at least in tissue sections.  However, in a separate in vitro study using cultured 
neurons from the hippocampus, clusters of α7 subunits were observed along the soma and 
dendrites and they were colocalized with presynaptic markers (169, 170).  Since most of these 
cultured neurons are pyramidal cells, this has been interpreted as segregation of α7 subunits into 
presynaptic terminals of these neurons, regulating the release of glutamate.  A physiological 
parallel is provided by the study where α7 receptors enhanced the release of glutamate at the 
mossy fibre-CA3 pyramidal cell synapses (171).  In comparison to α7, β2 subunits were localized 
in the cell body in a diffuse way in cultured hippocampal cells, suggesting specific segregation of 
different subtypes of receptors into different subcellular compartments.  The discrepancy between 
studies using cultured cells and tissue sections for aggregation of α7 immunoreactivity could be 
due to the system used, that is, in vivo vs. in vitro, and awaits further detailed characterization. 
 
Functional Evidence for Cholinergic Transmission 
Direct isolation of postsynaptic responses mediated by nicotinic receptors was made possible 
by recent studies that employed detailed electrophysiological analysis.  Thereby, functional 
cholinergic synapses were demonstrated in various principal cells and interneurons of different 
brain regions.  Spontaneous or nicotinic agonist-mediated postsynaptic responses were observed 
in a number of brain areas, e.g. neurons in the interpeduncular nucleus  and medial habenula (172, 
173), nucleus ambiguus of the brain stem (174), medial vestibular nucleus (175) and low-
threshold spike cells in layer 5 of the rat visual cortex (176). 
Fast cholinergic synaptic transmission with interesting physiological implications was found in 
the  developing ferret visual cortex (177), apart from peripheral synapses of retinal ganglion cells 
(178).  Some principal cells and interneurons in the developing ferret visual cortex displayed 
spontaneous EPSCs and also stimulation of thalamic afferents elicited cholinergic postsynaptic 
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responses.  Synaptic currents were insensitive to α-BTX, excluding the α7 class of receptors.  
Interestingly, an increase in this widespread nicotinic synaptic transmission coincided with  the 
period of eye-opening, suggesting a role of nicotinic receptors in synaptogenic events or circuit 
remodeling in this period. 
In addition to these studies, with the importance of the hippocampus as a structure mediating 
learning and memory and with the aid of its relatively well-defined circuitry, much attention has 
been drawn to the synaptic functions of nicotinic receptors in the hippocampus, revealing detailed 
aspects of cholinergic functions and also receptor subtypes mediating those.  Pyramidal cells and 
interneurons of the hippocampus receive cholinergic innervation from the medial septum-
diagonal band complex of the basal forebrain (179-181).  Although α7 subtype-mediated synaptic 
currents have been reported in pyramidal neurons of the CA1 area in some cases, generally they 
appear not to carry functional nicotinic synapses (182-184).  Interneurons in the CA1 field, 
however, express multiple components of nicotinic responses that differ in kinetic properties and 
pharmacological profiles.  Further, different populations of interneurons express different 
functional subtypes and some express multiple classes of receptors, revealing complexity of the 
cholinergic synapses.  The main, rapidly depolarizing synaptic response in CA1 interneurons is 
mediated by α7 receptors whereas the rest of the slowly depolarizing components are mediated by 
other classes comprising α2-α5 and β2-β4, which overall can be grouped into four 
pharmacologically different subtypes (169, 184-187).  In support of electrophysiological 
observations, α-BTX binding sites were found at the underlying synapses on interneuronal 
somata where cholinergic boutons appear to synapse (179, 188). 
Excitation of these interneurons will influence the activity of a large number of principal cells, 
and thereby coordinating overall hippocampal output (138).  Another intriguing physiological 
significance of cholinergic synapses in the hippocampus is provided by the study where activation 
of α7 receptors enhances the LTP induction process in the CA1 shaffer collateral/commissural 
pathway (189). 
Further approaches, combining electrophysiology with immunocytochemistry using high-
affinity antibodies specific for nicotinic subunits, will help to understand better the location and 
postsynaptic architecture of cholinergic synapses in the CNS. 
 
 
7.  Postsynaptic Assembly: from the NMJ to the Nervous System 
  
Anchoring and clustering of neurotransmitter receptors at functional sites are a critical task for 
neurons to perform efficient synaptic transmission.  A number of synaptic components including 
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clustering molecules have been identified for other neurotransmitter receptors (190, 191).  
Especially, existence of multiple isoforms for some synaptic molecules such as the PSD95 family 
of proteins further impose complicated features of the CNS synapses.  However, to date, very 
little information is available for the question of how cholinergic synapses in the nervous system 
are constructed and maintained, especially in the CNS.  One plausible hypothesis would be that 
structural and signaling components, which have been characterized at the NMJ, are also involved 
in the assembly of the postsynaptic scaffold in the nervous system.  Indeed, many molecules of 
the NMJ are also expressed in the PNS and CNS, and some, such as the D/UGC, appear to 
assemble into functional complexes in a similar way as in the muscle (192, 193).  However, 
except rapsyn, the relationship between these proteins and nicotinic synapses has not been 
systematically investigated so far.  Another possibility is that interneuronal cholinergic synapses 
are associated with as yet unidentified postsynaptic scaffolding proteins.  Eventhough gephyrin is 
involved in clustering of glycine and GABAA receptors, it does not appear to be a synaptic 
component of cholinergic synapses (143).   
 
Agrin May Play a Role in Postsynaptic Assembly at CNS Synapses 
Several studies have addressed the question of whether agrin, in analogy to its crucial role at 
the NMJ, plays a similar role in the formation of CNS synapses, however, the outcome is unclear 
at present.  Agrin is widely expressed in the CNS, with prominent levels in the hippocampus and 
olfactory bulb (194).  In agrin-deficient mice, synaptic localization and clustering of glutamate 
and GABAA receptors were not affected in the hippocampus, neither in tissue sections nor in 
cultured neurons (195).  Similarly, glutamatergic and GABAergic synapses are formed normally 
in cultured cortical neurons derived from agrin -/-mice, as was tested using immunocytochemical 
and functional analysis (196).  In contrast, in in vitro studies using hippocampal cultured neurons, 
suppressing the expression of agrin by treatment with antisense oligonucleotides or agrin-
antibodies resulted in the formation of fewer synapses that were functionally inefficient (197, 
198).  The discrepancy among these studies might be due to compensatory synaptogenic 
mechanisms in vivo operating in the agrin-deficient mice.  However, some indirect lines of 
evidence suggest that agrin might be involved in the formation of the interneuronal synapses, 
including postsynaptic assembly.  For example, agrin expression in the developing cortex 
coincides with the formation of thalamocortical and intracortical synapses (199).  Also, during 
development of the retina, agrin is redistributed from an initial diffused state to a punctate pattern 
in the inner and outer plexiform layers where it is concentrated within the synaptic clefts (200, 
201).  Moreover, in cultured retinal neurons, clusters of agrin colocalize at synaptic sites with 
gephyrin, one of the markers of inhibitory synapses, and purified retinal agrin induces AChR 
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clustering in cultured myotubes (202).  These results suggest a role of agrin in postsynaptic 
assembly, including receptor clustering, at synapses in the retina.  However, in the CNS, studies 
about localization and expression of agrin have so far not investigated the presence of agrin at 
synapses in detail.  Recently, a new form of agrin in which the NtA domain of the N-terminus is 
replaced by a cell surface-associating transmembrane domain was isolated from murine species 
and was found to be  expressed mainly in the brain (88, 203).  This isoform was also able to 
cluster AChRs in myotube cultures, suggesting that it might play a role in clustering of nicotinic 
or other receptors at the CNS interneuronal synapses. 
With respect to cholinergic synapses, agrin is expressed in neurons of the chick ciliary 
ganglion (204).  Agrin is also expressed by the innervating cholinergic neurons of the Edinger-
Westphal nucleus: this expression, along with agrin expression in ganglionic neurons, coincides 
with the periods of synapse formation and clustering of AChRs (205).  In tissue culture, agrin 
from agrin-expressing CHO cells arrests the neurite outgrowth of ciliary neurons and induces 
aggregation of the synaptic vesicle protein, synaptotagmin, suggesting an effect on presynaptic 
differentiation (206).  Therefore, agrin may play roles both in pre- and post-synaptic 
differentiation at cholinergic synapses in the ciliary ganglion, reminiscent of its roles at the 
vertebrate NMJ.   
 
Rapsyn Is not Required for Clustering of Ganglionic AChRs 
Rapsyn, which is essential for the formation of AChR clusters at the NMJ, can cluster neuronal 
nicotinic receptors of α7, α3/β2, α3/β4 or α4/β2 combinations and the α1,β1,γ2-GABAA 
receptor complex in heterologous cells (137, 207, 208).  However, evidence supporting rapsyn as 
a clustering molecule in neurons is lacking.  Rapsyn mRNAs, including several shorter splice 
variants that are not active in clustering of neuronal AChRs (differently from the full length form) 
are readily detected in chick ciliary and mouse superior cervical ganglia, while the expression 
level in the brain is very low (137, 208, 209).  In these studies, however, rapsyn immunoreactivity 
was not detected in ganglionic neurons (137, 208).  Most importantly, clusters of ganglionic 
AChRs containing α5 and β2 subunits are present in normal number, size and densities in 
superior cervical ganglia of mice lacking rapsyn, showing that rapsyn is not required for 
clustering of ganglionic AChRs (137).  The reason for the expression of rapsyn transcripts 
without proteins in neurons is not clear, but could imply that, in the nervous system, rapsyn might 
play a different role than clustering. 
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Components of the D/UGC Are Associated with Interneuronal Synapses in the PNS and 
CNS 
Dystrophin, the major component of the D/UGC in muscle, is expressed in neurons of the PNS 
and CNS.  Immunohistochemical and biochemical analysis demonstrated that dystrophin is 
associated with the PSDs in mouse superior cervical ganglia, some neurons of the cortex and 
cerebellar purkinje cells, and is found along the soma and dendrites as clusters in the CNS 
neurons (210-213).  In addition to the muscle type, a number of short forms of dystrophin-related 
gene products that still carry critical interaction domains with other D/UGC proteins have been 
identified in the nervous system, although functional roles of those are not clear (192, 212, 214, 
215).  There exists some evidence that these different gene products are localized at different 
synaptic sites (212).  Synaptic functions of dystrophin have been implicated in some studies.  
Clusters of α1 and β2 subunits of GABAA receptors were colocalized with dystrophin 
immunoreactivity in the hippocampus and cerebellum and they were markedly reduced in 
dystrophin-deficient mdx mice, while there was no change in the number of gephyrin clusters 
(213).  This suggests that dystrophin is involved in the synaptic localization of at least some 
subpopulations of GABAA receptors.  A possible link between synaptic AChRs and the D/UGC is 
found in the following studies. Ganglionic axotomy generated a coinciding reversible decrease of 
immunoreactivity of β-dystroglycan, dystrophin and α3 AChR subunits in the mouse superior 
cervical ganglion, which preceded the decrease in the number of intraganglionic synapses (216). 
In addition, synaptic localization of α3 AChR subunits, α- and β-dystroglycan was reduced in the 
superior cervical ganglion of mdx mice (which lack full-length dystrophin but still express short 
dystrophin isoforms).  These findings suggests that full-length dystrophin is involved in the 
synaptic localization of α3, by associating with these receptors in the same synaptic complex 
(217). Therefore, dystrophin appears to be associated with synaptic GABAA and nicotinic 
receptors eventhough the role as a synaptic component is not entirely clear. 
β-dystrobrevin and α-dystrobrevin-1, members of the dystrobrevin gene family, are mainly 
expressed in neurons and glia, respectively (215).  β-dystrobrevin is enriched at postsynaptic 
densities of major neurons in the brain and its expression pattern resembles that of dystrophin.  β-
dystrobrevin can be isolated together with syntrophin and dystrophins from the brain, indicating 
the presence of a complex similar to the muscle D/UGC (215, 218).  However, the molecular 
architecture of these protein complexes appears to be different between the muscle and the brain 
since, in dystrophin-deficient mdx mice, dystrobrevin-syntrophin complexes are still formed in 
the brain, whereas their assembly is disrupted in the muscle (215).  The presence of β-
dystrobrevin in the brain, but not in the muscle, further illustrates the structural difference of the 
muscle and brain forms of the D/UGC (214). 
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Syntrophin, another D/UGC component, also exists as multiple forms encoded by distinct 
genes.  Two novel variants of human origin, γ1 and γ2 isoforms, have been cloned recently and 
are expressed in neurons of the brain, mainly the cortex and hippocampus, decorating the soma 
and proximal dendrites (219).  Other syntrophins (α1 and β2)  are also expressed in the 
hippocampus and their mRNAs colocalize with those of dystrophins (192).  All of these 
syntrophin isoforms can bind to dystrophin as shown by in vitro assays (219, 220) 
Dystroglycans and utrophin also are expressed in neurons in an analogous manner to the above 
D/UGC proteins, but they appear to also decorate some microvasculature structures and glia (221, 
222).  Utrophin tends to label neurons differently from dystrophin in a non-overlapping manner, 
not only on the cellular but also subcellular levels, suggesting possibly different functional roles 
between them (223).   
Although these studies indicate that components of the muscle D/UGC are widely expressed in 
the brain, some at synaptic sites, and can form similar complexes, functional roles of these 
proteins with respect to CNS synapse formation have not been unequivocally established.  So far, 
sodium channels have been isolated as a binding partner for syntrophin, therefore, indicating that 
components of the D/UGC can be directly associated with neuronal ion channels (224).  It 
remains to be determined whether direct association with neurotransmitter receptors also 
underlies the suggested role of dystrophin at central GABAergic and peripheral cholinergic 
synapses (see above). 
 
Possible Roles of Presynaptic Input and the Cytoskeleton in Maintaining Synaptic AChRs 
Maintenance of the high synaptic density of AChRs at the NMJ requires activation of these 
receptors (125).  Some studies suggest that this might also be the case for cholinergic synapses in 
the PNS.  In frog cardiac ganglion neurons, large/dense clusters of AChRs at synaptic sites were 
dispersed into small clusters over the cell surface by denervation (135).  However, synaptic 
activity-dependent activation of receptors does not appear to be necessary for the development of 
all classes of receptor clusters, as has been mainly investigated by in vitro assays using cultured 
neurons.  Although glutamatergic and glycinergic inputs are necessary for clustering of AMPA 
and glycine receptors, respectively, clustering of NMDA and GABAA receptors does not require 
cognate presynaptic input (225-228).  Therefore it appears that organization of different classes of 
synapses requires not only different synaptic modules, but also different modes of activity-based 
regulation.  A close correlate to the NMJ is found in another aspect of the peripheral nervous 
system, that is, in chick ciliary ganglion neurons, presynaptic input induces the expression of 
AChR mRNAs during synaptogenesis and also maintains their expression (229, 230). 
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The cytoskeleton is an important component for anchoring neuronal receptors at synaptic sites, 
and the regulation of cytoskeletal assembly serves as a mechanism for stabilizing or destabilizing 
synaptic receptor-complexes for a number of neuronal receptors.  So far, tubulin and actin have 
been identified as cytoskeletal elements that regulate clustering events of GABAA and glutamate 
receptors (191, 231, 232).  Interaction of receptors with the  cytoskeleton occurs mostly through 
clustering molecules such as gephyrin, GABARAP and PSD95, although direct interactions also 
occur (191, 233-235).  Evidence for interaction of neuronal nicotinic receptors with the 
cytoskeleton is limited to ganglionic α7 receptors (see above).  Although anchoring phenomena at 
postsynaptic densities found for ganglionic AChR subunits as well as for CNS subunits such as 
α4, suggest involvement of the cytoskeleton for synaptic localization of these receptors, there has 
been no study supporting this hypothesis. 
 
 
8. Conclusions 
 
Mechanisms of postsynaptic assembly that were established at the NMJ potentially serve as 
good models for understanding synaptic development of interneuronal synapses.  Whether 
development of the neuronal cholinergic synapses requires some of the molecules that have been 
identified at the NMJ or it depends on unique build-up machinery is an intriguing open question.  
For example, rapsyn, an essential component for clustering of AChRs at the NMJ, is dispensable 
for clustering of neuronal nicotinic receptors.  However, actin filaments are required for 
maintaining clusters of both muscle and neuronal AChRs and some D/UGC proteins are 
associated with peripheral cholinergic synapses.  Considering different classes of neuronal 
receptors that are segregated in a given synapse, as demonstrated in peripheral ganglia, it is also 
tempting to question how these unique synaptic structures and functions are formed and 
maintained. 
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Figure legends 
 
Figure 1. The postsynaptic apparatus at the neuromuscular junction. Postsynaptic proteins 
and their interactions are illustrated. For simplicity, not all isoforms of synaptically located 
proteins are shown. Similarly, segregation of isoforms between the crests and troughs of 
postjunctional folds is neglected. p, tyrosine phosphorylation. 
 
Figure 2. Steps in the assembly of the postsynaptic membrane at the NMJ. A, In the absence 
of nerve-derived agrin, at least two pre-assembled signaling complexes exist in the muscle 
membrane, an AChR complex and a MuSK complex. Assembly of these complexes may in part 
occur in the secretory pathway, since some of their components colocalize in post-Golgi vesicles. 
Two main local signaling events leading to AChR clustering in response to agrin are depicted. In 
the MuSK complex, which may act as a primary synaptic scaffold, agrin causes rapid activation 
of MuSK and recruitment of Src and Fyn to MuSK, leading to MuSK phosphorylation. In the 
AChR complex, agrin activates MuSK rapidly; in a rapsyn-dependent way, AChR-bound Src and 
Fyn are then autophosphorylated, and AChR β and δ subunits are tyrosine-phosphorylated. 
Further elements involved are Calcium fluxes, activation of Rac and Cdc42, NO and actin 
filaments, which are all required for formation of AChR clusters. B, After prolonged treatment 
with agrin, clusters of postsynaptic proteins are formed, at least in part by a rapsyn-dependent 
linkage of the pre-assembled AChR complexes shown in A to the MuSK complex/primary 
synaptic scaffold. α-DG, α-dystroglycan; p, tyrosine phosphorylation.  
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Table I. Proteins necessary for stabilization of AChR clusters 
 
 
 
Protein Effect of absence of active 
protein 
 
Experimental approach Reference 
Dystroglycan Fragmentation of 
postsynaptic membrane, 
muscular dystrophy 
 
Rapid dispersal of 
fragmented AChR clusters 
Chimaeric mice lacking 
dystroglycan in some muscle 
fibers 
 
Withdrawal of agrin from 
agrin-treated dystroglycan-
deficient myotubes 
 
Cote et al., 1999 
(108); Jacobson et 
al., 2001 (93) 
Dystrobrevin Fragmentation of 
postsynaptic membrane, 
less postjunctional folds, 
muscular dystrophy 
 
Rapid dispersal of AChR 
clusters 
α-dystrobrevin -/- mice 
 
 
 
 
Withdrawal of agrin from 
agrin-treated α-dystrobrevin -/- 
myotubes 
 
Grady et al., 1999, 
2000 (111, 109) 
Src and Fyn Normal NMJ around birth 
 
 
Rapid dispersal of AChR 
clusters 
Src-Fyn-deficient mice 
 
 
Withdrawal of agrin from 
agrin-treated src -/- ; fyn -/- 
myotubes 
 
Smith et al., 2001 
(54) 
TrkB Disruption of AChR 
clusters at the NMJ 
 
 
 
Disruption of AChR 
clusters 
Adenovirus-mediated 
expression of dominant-
negative TrkB in muscle in 
mice 
 
Adenoviral expression of 
dominant-negative TrkB in 
agrin-treated myotubes 
 
Gonzalez et al., 1999 
(118) 
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